Rex C. Haydon to Trans-Activators
This is a "connection" page, showing publications Rex C. Haydon has written about Trans-Activators.
Connection Strength
0.394
-
Cytoplasmic and/or nuclear accumulation of the beta-catenin protein is a frequent event in human osteosarcoma. Int J Cancer. 2002 Dec 01; 102(4):338-42.
Score: 0.181
-
Wnt/beta-catenin signaling pathway as a novel cancer drug target. Curr Cancer Drug Targets. 2004 Dec; 4(8):653-71.
Score: 0.052
-
Tyrosine kinase inhibitor STI-571/Gleevec down-regulates the beta-catenin signaling activity. Cancer Lett. 2003 Apr 25; 193(2):161-70.
Score: 0.046
-
Fluorescence-based functional assay for Wnt/beta-catenin signaling activity. Biotechniques. 2002 Nov; 33(5):1126-8, 1130, 1132 passim.
Score: 0.045
-
Elevated protein expression of cyclin D1 and Fra-1 but decreased expression of c-Myc in human colorectal adenocarcinomas overexpressing beta-catenin. Int J Cancer. 2002 Oct 01; 101(4):301-10.
Score: 0.045
-
Connective tissue growth factor (CTGF) is regulated by Wnt and bone morphogenetic proteins signaling in osteoblast differentiation of mesenchymal stem cells. J Biol Chem. 2004 Dec 31; 279(53):55958-68.
Score: 0.013
-
Inhibitor of DNA binding/differentiation helix-loop-helix proteins mediate bone morphogenetic protein-induced osteoblast differentiation of mesenchymal stem cells. J Biol Chem. 2004 Jul 30; 279(31):32941-9.
Score: 0.013